Treatment paradigms in Parkinson's Disease and Covid-19.

Boura, Iro; Batzu, Lucia; Dietrichs, Espen; Ray Chaudhuri, Kallol

Boura, Iro; Batzu, Lucia; Dietrichs, Espen; Ray Chaudhuri, Kallol.

Afiliação

Boura I; Medical School, University of Crete, Heraklion, Crete, Greece; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation
Batzu L; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Dietrichs E; Department of Neurology, Oslo University Hospital and University of Oslo, Oslo, Norway.
Ray Chaudhuri K; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Int Rev Neurobiol ; 165: 135-171, 2022.

Article em En | MEDLINE | ID: mdl-36208898

Assuntos

COVID-19; Doença de Parkinson; Humanos; Doença de Parkinson/complicações; Doença de Parkinson/diagnóstico; Doença de Parkinson/terapia

Palavras-chave

Covid; Hospitalization; Management; Pandemic; Parkinson; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / COVID-19 Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Int Rev Neurobiol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google